Related Experiment Video
Updated: Feb 9, 2026

Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
Patient-controlled deep brain stimulation can overcome analgesic tolerance
Pantaleo Romanelli1, Gary Heit
1Department of Neurosurgery, Stanford University Medical Center, CA 94305-5327, USA.
Patient-controlled stimulation restored pain relief when tolerance to deep brain stimulation (DBS) developed. This technique offers a new approach for managing chronic neurogenic pain unresponsive to conventional DBS therapy.
Area of Science:
- Neuroscience
- Pain Management
- Neurosurgery
Background:
- Deep brain stimulation (DBS) is a neuromodulation technique used to treat various neurological conditions, including chronic pain.
- Tolerance to DBS, characterized by a loss of therapeutic effect over time, can limit its long-term efficacy.
- Neurogenic pain following cerebellar stroke presents a significant challenge for pain management.
Observation:
- A patient with neurogenic pain experienced successful analgesia with right ventralis caudalis (VC) thalamus DBS for 29 months.
- Tolerance to the established DBS therapy developed, leading to a complete loss of pain relief.
- The patient's analgesia was successfully restored by switching to a stimulation module enabling patient-controlled stimulation.
Findings:
- A novel technique utilizing patient-controlled stimulation effectively reversed tolerance to DBS-induced analgesia.
- This method allowed the patient to regain pain control by actively managing stimulation parameters.
- Restoration of analgesia was achieved without altering the implanted DBS hardware, only the stimulation control method.
Implications:
- Patient-controlled stimulation may be a viable strategy to overcome or delay tolerance development in DBS therapy for pain.
- This approach could enhance the long-term effectiveness and patient satisfaction with DBS for chronic pain management.
- Further research into patient-controlled neuromodulation is warranted for optimizing treatment outcomes in refractory pain conditions.
Related Concept Videos
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Opioid Analgesics: Morphine and Other Natural Cogeners
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Control System Problem
When forming a closed-loop system, issues can arise if the poles cross into the unstable region, leading to potential...

